AZP-3601 SAD and MAD Study in Healthy Subjects and Subjects With Hypoparathyroidism

Learn more about:
Related Clinical Trial
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism A Survey to Assess Participants’ and Physicians’ Knowledge, Attitudes and Behavior When Using NATPARA PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism AZP-3601 SAD and MAD Study in Healthy Subjects and Subjects With Hypoparathyroidism Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism Near-infrared Autofluorescence (NIRAF) in Total Thyroidectomy: Impact in Low-volume, Non-parathyroid Centers Preoperative Lugol’s Solution in Graves’ Disease and Toxic Nodular Goiter A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1) Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test After Total Thyroidectomy Predicting Risk Factors of Postoperative Hypocalcemia After Total Thyroidectomy Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism Magnesium Treatment in Hypoparathyroidism Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism Corticosteroid Rhythms in Hypoparathyroid Patients A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism Bone Properties in Hypoparathyroidism: Effects of PTH ADD-ON Study to Existing Hypoparathyroidism Studies Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism – A Clinical Extension Study in Hungary Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism. Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism Evaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism (EMPATHY) Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara) Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY) Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism – A Clinical Extension Study (RACE) Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy Burden of Illness in Hypoparathyroidism Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism Use of NPSP558 in the Treatment of Hypoparathyroidism

Recruitment Information


Administrative Informations